Moderna Outperforms Q1 Revenue Expectations on Strong International COVID Vaccine Demand
Moderna reported first-quarter revenue that exceeded Wall Street expectations, driven by outsized international sales of its COVID-19 vaccine and support from distribution partnerships in the UK, Canada and Australia. The company recorded $389 million in revenue, with $311 million coming from international markets versus $78 million in the U.S., an…